Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi: uniqure.com (QURE)
uniQure N.V. (QURE) maintains business resilience through a safe liquidity buffer and the development of new pipelines. The operating cash flow volume visualizes this trend, where the 0.00 mark serves as a key metric. Revenues rely on royalties from HEMGENIX sales via CSL Behring. Supply reliability is guaranteed by strict temperature controls and isolation during the transport of drugs to specialized centers.
uniQure - rincian analitis lan metrik utama (QURE)
- rega pasar lan target rega analis:
- indikator kapitalisasi bursa perusahaan:
- informasi kapitalisasi buku:
- rincian struktur utang lan likuiditas bisnis:
Rasio Utang marang Ekuitas uniQure N.V.|QURE - Rasio utang jangka dawa marang ekuitas|Koefisien utang jangka cendhak marang modal uniQure NV|QURE - Gunggung utang perusahaan|Rasio utang marang kapitalisasi buku uniQure|QURE - Kewajiban jangka dawa perusahaan|Gunggunge utang jangka cendhak uniQure|Likuiditas kritis uniqure.com
- rincian bathi lan kelipatan pasar:
QURE - Penghasilan resik|Proyeksi bathi mangsa ngarep uniQure N.V.|QURE - Rasio rega marang bathi|Pangali mangsa ngarep rega marang bathi uniqure.com|QURE - Pangali PEG|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan uniQure|QURE - Bathi operasional EBITDA|Bathi saben saham sajrone 12 wulan pungkasan uniQure|QURE - Bathi saben saham sajrone rolas wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone 12 wulan pungkasan uniqure.com|QURE - Wutah bathi ing taun lumaku|Prakiraan wutah bathi kanggo taun ngarep uniQure N.V.
- indikator dodolan lan pendapatan:
Pambiji fundamental perusahaan:uniQure Pharma (QURE)
The investment attractiveness of uniQure N.V. (QURE) depends on its ability to generate internal resources amid biotech sector volatility. This metric measures the actual cash flow from core operations before interest and taxes, reflecting the fundamental efficiency of the business. By analyzing the operating cash result on GURU.Markets, an investor assesses the company's resilience to geopolitical risks and disruptions in European supply chains. Growth in this indicator confirms the ability to fund clinical trials without external borrowing. Stable positive dynamics guarantee capital preservation and long-term growth.
Analisis pesaing uniQure N.V.
Bathi operasional EBITDA Tempus TEM|QGEN - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi IONS (ionispharma.com)|RGEN: Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Avidity Biosciences Inc (RNA)|Bathi operasional sadurunge ngurangi amortisasi CRSP|WGS: Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Ultragenyx Pharmaceutical (RARE)|beamtx.com - Bathi operasional sadurunge amortisasi|Sarepta - Bathi operasional sadurunge ngurangi amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Twist Bioscience Inc (TWST)|TXG: Bathi operasional sadurunge ngurangi amortisasi|NTLA: Bathi sadurunge mbayar bunga, pajak, lan amortisasi|STOK (Stoke Therapeutics) - Bathi operasional sadurunge ngurangi amortisasi|BLFS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Wave Life Sciences Ltd.|MAZE - Bathi operasional sadurunge potongan amortisasi|Bathi operasional sadurunge ngurangi amortisasi SION (Sionna Pharma)|Bathi operasional EBITDA Prime Medicine Bio (PRME)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Taysha Gene Therapies TSHA|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi MGTX|REGENXBIO - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Solid Biosciences Inc|OCGN: Bathi operasional EBITDA|Bathi operasional sadurunge amortisasi PACB|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Benitec Biopharma Inc.|Bathi operasional sadurunge amortisasi DSGN (designtx.com)|Bathi operasional EBITDA RCKT|Bathi operasional EBITDA 4DMT (FDMT)|Lexeo Therapeutics, Inc. - Bathi operasional sadurunge ngurangi amortisasi|Bathi operasional EBITDA Korro Bio Inc. KRRO|EDIT - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|SLN (silence-therapeutics.com) - Bathi operasional sadurunge amortisasi|PRQR: Bathi operasional EBITDA|CDXS - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Sangamo|NAUT - Bathi operasional sadurunge potongan amortisasi|Bathi operasional sadurunge ngurangi amortisasi MGX (Metagenomi, Inc.)|Bathi operasional EBITDA precisionbiosciences.com (DTIL)|Bathi sadurunge mbayar bunga, pajak, lan amortisasi Generation Bio GBIO|Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi BOLD|Exicure Corp - Bathi operasional EBITDA|Bathi sadurunge bunga, pajak, lan amortisasi Imunon, Inc.|PHIO (phiopharma.com) - Bathi operasional sadurunge ngurangi amortisasi|Mustang Bio - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi sadurunge mbayar bunga, pajak, lan amortisasi TransCode Therapeutics Inc.|Bathi operasional sadurunge amortisasi BNGO (Bionano)|Bathi operasional sadurunge ngurangi amortisasi APDN (Applied DNA)|Pendapatan operasional sadurunge ngurangi amortisasi bluebird bio, Inc|ImmunoPrecise Antibodies Ltd. - Bathi operasional sadurunge ngurangi amortisasi|omegatherapeutics.com - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|OMIC: Bathi operasional sadurunge ngurangi amortisasi|Pendapatan operasional sadurunge ngurangi amortisasi Regulus Therapeutics, Inc. RGLS|Syros (SYRS) - Bathi sadurunge mbayar bunga, pajak, lan amortisasi|Bathi operasional sadurunge potongan amortisasi Telesis Bio, Inc TBIO|Bathi operasional sadurunge ngurangi amortisasi TCON|Bathi operasional EBITDA unitybiotechnology.com
